← All trials
NCT01314859
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2011
- Primary completion
- Jul 1, 2012
- Completion date
- Jul 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of SantiagoLead sponsor
- Hospital Universitari Son DuretaOverall official - principal investigator
- Complexo Hospitalario de OurenseOverall official - principal investigator
- Complexo Hospitalario de PontevedraOverall official - principal investigator
- University of CorunaOverall official - principal investigator
- Complexo Hospitalario Arquitecto MarcideOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.